RARE — Ultragenyx Pharmaceutical Inc. | XLV Holdings | StockAdder

(RARE)

Ultragenyx Pharmaceutical Inc.

Live chart and latest RARE stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

RARE News

Ultragenyx Pharmaceutical Inc. $RARE Stock Position Cut by SG Americas Securities LLC

Apr 11, 2026 Seeking Alpha

Ultragenyx Pharmaceutical: The Market Is Overlooking 2026 Catalysts (NASDAQ:RARE)

Apr 12, 2026 Stock Titan

FDA starts review of Ultragenyx gene therapy for fatal child disease

Apr 2, 2026 National Today

Rep. Gilbert Ray Cisneros, Jr. Buys Ultragenyx Pharmaceutical Inc. Shares

Apr 11, 2026 Yahoo Finance

Why Ultragenyx Pharmaceuticals Stock Is Plummeting Today

Dec 29, 2025 MSN

Ultragenyx (RARE) shares positive results from DTX301 phase 3 study

Apr 5, 2026 Quiver Quantitative

Ultragenyx Pharmaceutical Inc. Grants 22,917 Restricted Stock Units to Newly Hired Non-Executive Officers

Feb 20, 2026 MarketBeat

Aberdeen Group plc Buys 496,295 Shares of Ultragenyx Pharmaceutical Inc. $RARE

Apr 5, 2026 Yahoo Finance

Analysts Lower Ultragenyx (RARE) Target but Stay Bullish

Jan 9, 2026 Stock Titan

Ultragenyx (RARE) CFO sells 4,683 shares, retains 80,351 stake

Apr 2, 2026 MarketBeat

Rep. Gilbert Ray Cisneros, Jr. Buys Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Shares

Apr 9, 2026 Yahoo Finance

A Look At Ultragenyx Pharmaceutical (RARE) Valuation After Revenue Beat And Gene Therapy Catalysts Update

Jan 13, 2026 MarketBeat

Ultragenyx Pharmaceutical (NASDAQ:RARE) Upgraded to "Strong-Buy" at Truist Financial

Mar 26, 2026 Yahoo Finance

Ultragenyx (RARE) Rockets 15.5% on Bargain-Hunting After Steep Fall

Dec 31, 2025 MarketBeat

Insider Selling: Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells 4,683 Shares of Stock